Try Claude
Lead FinderFind & enrich companies and people
AI Tools for Neuroscientists
AI tools that help neuroscientists search literature, find clinical trial data, analyze drug information, and compile research reports.
Get started for free
Works in Chat, Cowork and Code
Title (abbrv.)JournalYear
Hebbian plasticity requires a calcium spikeNature Neuroscience2022
Engram cells retain memory under amnesiaScience2021
mTOR-dependent LTP in hippocampal CA1Neuron2023
Astrocyte-neuron synapse signaling in LTPCell2022
Sorted by citation count · peer-reviewed only
Neuroscience literature review
Search tens of millions of peer-reviewed papers across neuropharmacology, cognitive neuroscience, computational neuroscience, and neuropathology. Find seminal papers, track citation networks, and synthesize literature for grant applications and publications.
Find the top cited papers on CRISPR-based gene therapy for Huntington's disease published since 2019, with author affiliations and key findings.
Found 14 papers. Top: "In vivo gene silencing by allele-specific CRISPR reduces HD pathology" (Nature Neuroscience, 2022, 476 citations). Results include journal, DOI, and main experimental approaches for each.
ToolRouter search_papers
Title (abbrv.)JournalYear
Allele-specific CRISPR silencing reduces HD pathologyNature Neuroscience2022
HTT exon 1 excision via base editing in miceNature Medicine2021
In vivo prime editing corrects CAG repeatScience2023
AAV-CRISPR delivery to striatum — safety studyBrain2020
14 papers found · sorted by citations
Clinical trials discovery
Search ClinicalTrials.gov for active, recruiting, and recently completed trials on any neurological condition or therapeutic target. Track competitors' pipelines, find trials for patient referral, or identify gaps in the clinical evidence base.
Find currently recruiting Phase 2 or 3 clinical trials for Alzheimer's disease targeting amyloid beta or tau, in the US or Europe.
Found 23 recruiting trials. Notable: lecanemab open-label extension (Phase 3, 8 sites), 2 tau-targeting ASO trials (Phase 2), and a novel tau PET imaging biomarker study. Includes NCT numbers and eligibility criteria.
ToolRouter search_trials
TrialPhaseTarget
Lecanemab open-label ext. (NCT05026866)Phase 3Amyloid β
BIIB080 tau ASO (NCT05108948)Phase 2Tau (ASO)
JNJ-63733657 (NCT04149860)Phase 2Phospho-tau
Tau PET biomarker substudy (NCT05474417)Phase 2Imaging
23 recruiting trials found · ClinicalTrials.gov
Drug information and pharmacology research
Pull FDA-approved drug labeling data for any CNS medication including mechanism of action, dosage, pharmacokinetics, adverse effects, and black box warnings. Useful for pharmacology reviews, prescribing support research, and drug interaction analysis.
Get full FDA labeling for clozapine including mechanism, dosage schedules, black box warnings, and drug-drug interactions with common antiepileptics.
Retrieved labeling: D2/5-HT2A antagonist, dosage 12.5-900mg/day with titration schedule, black box warnings for agranulocytosis and seizure threshold lowering. Key interaction: carbamazepine increases agranulocytosis risk — avoid combination.
ToolRouter search_drug
Mechanism
D2/5-HT2A antagonist · atypical antipsychotic
Dosage Range
12.5–900mg/day with mandatory titration schedule
Black Box: Agranulocytosis
ANC monitoring required — REMS program mandatory
Black Box: Seizures
Dose-dependent threshold lowering — risk at >600mg
Key Interaction
Carbamazepine + clozapine = increased agranulocytosis risk — avoid
Neurological pathway diagram generation
Create labeled diagrams of neural circuits, signaling cascades, pharmacological pathways, and experimental workflows. Produce publication-quality figures directly from text descriptions for papers, talks, and grant figures.
Draw a diagram of the mTOR signaling pathway in neurons, highlighting how BDNF activates TrkB and downstream PI3K-Akt-mTOR for synaptic protein synthesis.
Generated labeled pathway diagram: BDNF → TrkB → PI3K → PIP3 → Akt → TSC1/2 → Rheb → mTORC1 → 4E-BP1/S6K1 → protein synthesis. Includes inhibitory nodes and AMPK cross-regulation.
Comprehensive research area review
Compile multi-source deep research reports on any neuroscience topic — disease mechanisms, therapeutic approaches, experimental models, or emerging technologies. Pull together the evidence base quickly for lab meetings, review articles, and proposal sections.
Compile a research summary on the role of neuroinflammation in ALS progression — key mechanisms, experimental evidence, and current therapeutic targets.
Compiled 18-source report: microglia/astrocyte activation via TDP-43 pathology highlighted as central mechanism, NF-κB and NLRP3 inflammasome pathways detailed, 4 current anti-inflammatory drug targets in clinical trials summarized.
ToolRouter research
Central Mechanism
Microglia/astrocyte activation via TDP-43 pathology
Key Pathways
NF-κB signaling · NLRP3 inflammasome activation
Therapeutic Targets
4 anti-inflammatory compounds in active clinical trials
Evidence Base
18 sources compiled · 12 peer-reviewed
Open Question
Causal vs. consequential role of inflammation debated
Regulatory and grant deadline tracking
Monitor NIH NINDS, Brain Research Foundation, and private foundation grant deadlines, plus neuroscience conference abstract submission windows. Keep the lab's funding pipeline on track.
Find upcoming NIH NINDS R01 deadlines and Society for Neuroscience abstract submission dates in the next quarter.
Found 6 events: NINDS R01 standard deadline February 5, NINDS R21 deadline April 5, SfN abstract submission opens April 1 (closes June 15), Dana Foundation LOI window opens March 15.
ToolRouter search_events
Feb 5
NINDS R01 Standard Deadline
Mar 15
Dana Foundation LOI Window Opens
Apr 1
SfN Abstract Submission Opens
Apr 5
NINDS R21 Deadline
Jun 15
SfN Abstract Submission Closes
Ready-to-use prompts
Literature search
Find the top 20 cited papers on GABAergic interneuron dysfunction in schizophrenia published since 2018. Include journal, citations, and key methods used.
Clinical trial search
Search recruiting clinical trials studying transcranial magnetic stimulation or deep brain stimulation for treatment-resistant depression in the US. Show Phase, sites, and contact info.
Drug labeling lookup
Get FDA labeling for ketamine hydrochloride, including approved indications, mechanism, dosage for anesthetic and antidepressant use, and side effect profile.
Pathway diagram
Draw a labeled diagram of the dopaminergic mesolimbic reward pathway from VTA to nucleus accumbens, showing D1 and D2 receptor subtypes and modulatory inputs.
Research topic review
Research the current state of exosome-based biomarkers for Alzheimer's disease diagnosis — what proteins are detected, sensitivity/specificity findings, and stage of clinical development.
Find collaborators
Find neuropharmacologists and molecular neuroscientists at top research hospitals in Boston and San Diego. Include their lab focus and affiliation.
Chemical compound lookup
Look up the chemical properties, pharmacological class, and mechanism of action of riluzole and compare it structurally with edaravone for ALS treatment.
Grant funding research
Research available NIH mechanisms for early-career neuroscientists studying neurodegenerative disease, including K99/R00, R21, and relevant foundation grants. Include current award sizes.
Tools to power your best work
Academic ResearchSearch papers, authors, citations
Deep ResearchAI research reports with citations
Drug InformationDrug info: recalls & side effects
Diagram GeneratorRender Mermaid, PlantUML & more
Chemistry LookupCompounds, elements, and safety
Economic CalendarEarnings, IPOs, FOMC & events
Clinical TrialsClinical trials & drug safety data
165+ tools.
One conversation.
Everything neuroscientists need from AI, connected to the assistant you already use. No extra apps, no switching tabs.
Grant application preparation
Assemble a compelling NIH R01 proposal with comprehensive literature review, clinical context from trial data, and clear mechanistic diagrams.
Drug target research workflow
Investigate a new CNS drug target by reviewing the literature, pulling existing drug labeling data, and identifying ongoing clinical trials.
Lab meeting literature update
Quickly compile a curated reading list and brief summary report for weekly lab meeting on a new topic or method.
Frequently Asked Questions
Can Academic Research find preprints in addition to peer-reviewed papers?
Academic Research focuses on peer-reviewed publications indexed in major scientific databases. For preprints on bioRxiv or medRxiv, a supplementary search using the Web Search tool with site-specific queries can surface those alongside the peer-reviewed literature.
How current is the clinical trials data?
Clinical Trials pulls directly from ClinicalTrials.gov, which is updated continuously as trials register new results, change status, or add recruitment sites. Data is typically within days of the official registry update.
Can I use Drug Information for veterinary or off-label research?
Drug Information covers FDA-approved drug labeling for human pharmaceuticals. Off-label uses sometimes appear in the literature references section of labeling. For veterinary pharmacology, Academic Research is the better tool to surface animal studies.
Can diagram generator produce figures suitable for publication?
Diagram Generator produces clean vector-style outputs that can be used in slide presentations and grant applications. For journal-submission-quality figures requiring precise formatting, the generated diagram works best as a draft that you refine in illustration software.
Is there a way to search for neuroscience conference presentations or posters?
Academic Research focuses on journal publications. For conference abstracts and posters, Deep Research can compile summaries from publicly accessible conference abstract books, and Web Search can surface Society for Neuroscience or other conference program databases.
Give your AI superpowers.
Get started for free
Works in Chat, Cowork and Code